Fmoc-Asn-OH, 98%, 25g

1-(4-fluorophenyl)-4-hydroxy-6-oxo-1,6-dihydropyridazine-3-carboxylic acid, 95.0%, 1g

5,7-Dichlorothieno[3,2-b]pyridine, 95.0%, 10g

2-Nitrobenzaldéhyde, min 98%, pour synthèse, 250 g, emballage plastique.

1,3-bis(3-chlorophenyl)propane-1,3-dione, 100mg

2,4-Dichloro-1-(trifluoromethoxy)benzene, 97%, 10g

Cyclobutanemethanol, 98.0%, 500g

4-Chlorophenyl cyclobutyl ketone, 97.0%, 100mg

N-(4-piperidinylmethyl)acetamide hydrobromide, 95.0%, 1g

tert-Butyl 3,6,9,12-tetraoxapentadec-14-yn-1-ylcarbamate, 95%, 100mg

6-Propoxypyridazin-3-amine, 95.0%, 5g

(R)-2-Methylpiperidine-2-carboxylic acid, 95.0%, 250mg

(Quinazolin-4-yloxy)-acetic acid ethyl ester, 1g